Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Brachiopod genome unveils the evolution of BMP signalling in bilaterian body patterning.

Nature communications·2026

Same author

Relationship between microplastics in stool, diet, and inflammatory markers in healthy Japanese individuals.

Environmental health and preventive medicine·2026

Same author

Zinc accumulation in the jaw of Nereis aibuhitensis.

The Journal of experimental biology·2026

Same author

Advance care planning in Japan: Gaps between policy, ethical understanding, and its translation into clinical practice.

Palliative care and social practice·2026

Same author

Randomized open-label non-inferiority trial of paracetamol or celecoxib for patients with chronic low back pain.

Scientific reports·2025

Same author

Quantum annealing-based route optimization for commercial AGV operating systems in large-scale logistics warehouses.

Scientific reports·2025

Search research articles

Related Experiment Video

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Biomarkers.

Keisuke Shimizu¹, Kenta Tosaka¹, Noboru Ogihara¹

¹TOSOH Corporation, Ayase-shi, Kanagawa, Japan.

Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association

|December 26, 2025

Summary

A new ultra-sensitive blood test system can detect Alzheimer's disease (AD) biomarkers at extremely low levels. This reproducible method improves detection accuracy for early AD diagnosis in aging populations.

Area of Science:

Biomarker Discovery
Medical Diagnostics
Biotechnology

Background:

Alzheimer's disease (AD) prevalence is increasing in aging populations.
Accurate detection of AD biomarkers in blood is crucial for assessing pathological stages.
Current methods struggle with the low concentrations and reproducibility of blood-based AD biomarkers.

Purpose of the Study:

To develop an ultra-sensitive and reproducible measurement system for detecting Alzheimer's disease (AD) biomarkers in blood.
To establish a novel platform applicable for early AD diagnosis.

Main Methods:

A measurement system was developed using brain natriuretic peptide (BNP) as a model biomarker.
The system utilizes anti-BNP antibody-modified magnetic beads for capture and enzyme labeling.

More Related Videos

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Related Experiment Videos

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

Ultra-sensitive detection is achieved by enclosing multiple beads in microwells for enhanced signal amplification and reproducibility.

Main Results:

The system achieved a limit of detection (LOD) of 2.5 fM (8.6 fg/mL) for BNP, significantly surpassing conventional immunoassay sensitivity.
Excellent reproducibility was demonstrated, with a coefficient of variation (CV) of 8.1% at 7.2 fM (25 fg/mL) BNP.
The developed system successfully detected an Alzheimer's disease marker.

Conclusions:

An ultra-sensitive and reproducible measurement system for blood-based biomarkers has been successfully developed.
This novel system shows significant potential for the accurate detection of Alzheimer's disease (AD)-related biomarkers.
The technology can be applied to improve early diagnosis and monitoring of AD.